Akero Therapeutics Inc.

NASDAQ: AKRO · Real-Time Price · USD
51.41
-1.95 (-3.65%)
At close: Jul 01, 2025, 3:59 PM
52.65
2.41%
After-hours: Jul 01, 2025, 05:50 PM EDT

Akero Therapeutics Revenue

Akero Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Akero Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
69
Market Cap
4.1B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.